Sinofn Health
Sinofn Health
Scientific Contract Manufacturing Excellence
Cutting-edge clinical solutions engineered for metabolic disorders, oncology recovery, and specific physiological dietary requirements.
Calgary, Alberta, represents one of Canada's most dynamic hubs for clinical healthcare innovation. Under the administration of Alberta Health Services (AHS), healthcare facilities such as the Foothills Medical Centre, Rockyview General Hospital, and the Alberta Children's Hospital are increasingly adopting advanced dietary therapies. Foods for Special Medical Purposes (FSMP) play a critical role in managing chronic metabolic conditions, critical oncology recoveries, and pediatric disorders.
The transition from legacy nutritional solutions to precision-targeted amino acid formulas, targeted protein lipids, and bio-available micro-nutrients is accelerating. Local distributors, clinical buyers, and healthcare systems in Calgary demand FSMP products that not only strictly comply with Health Canada's regulatory standards but also provide exceptional supply chain security, cost efficiency, and formula stability.
During her clinical career, Mrs. GuoHong Liu witnessed the lifelong struggle of children diagnosed with Phenylketonuria (PKU) — where specialized dietary products were financially out of reach for many families. Guided by a purpose-driven resolve to bridge this therapeutic gap, Mrs. Liu founded SINOFN in 2012. Her goal was clear: to build a high-technology manufacturing enterprise dedicated to developing affordable, scientifically optimized clinical nutrition.
What began as a regional project to make PKU foods accessible has evolved into a global powerhouse in contract manufacturing. Supported by strategic academic integrations, SINOFN now delivers advanced FSMP formulation technologies, clinical supplements, and specialized dietary foods to healthcare brands worldwide.
"We measure success not just in raw supply capacities, but in the lives globally enriched through accessible medical science and clinical nutrition."
- Mrs. GuoHong Liu, FounderSINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the prestigious Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the global trading and partnership hub, bringing high-tech contract manufacturing services to partners in Calgary, North America, and Europe.
Through our partnerships with top research institutions and our dedicated laboratories, we bridge the gap between academic innovation and high-throughput production. Our focus on scientific research ensures every batch meets international guidelines for medical diets. We conduct rigorous stability testing under varying temperature and humidity protocols to guarantee performance throughout the global logistics lifecycle.
Elite scientific minds steering specialized health science research, pharmaceutical-grade formulation design, and international regulatory compliance.
Ph.D. from Peking University Medical School. Brings over 15 years of focus to metabolic disorder formulations, specializing in amino acid profile design for pediatric PKU diets.
Associate Researcher and Postdoctoral Fellow of the Chinese Academy of Sciences. Specialist in bioactive compound delivery systems and molecular stabilization protocols.
Senior Scientist from the Netherlands. Expert in EU/North American regulatory compliance frameworks, dietary delivery innovations, and manufacturing scale-up engineering.
Developing effective medical nutrition demands strict pharmaceutical precision, biological analysis, and reliable manufacturing practices.
For patients with Phenylketonuria, standard proteins must be completely avoided and replaced with free-form amino acids. Our technological roadmap relies on advanced amino acid blending that eliminates bitter tastes while preserving nutrient stability. These formulations are fortified with vitamins, minerals, and essential fatty acids (DHA/ARA) to match natural growth profiles.
Bioactive compounds such as Pyrroloquinoline quinone (PQQ) and Medium-Chain Triglycerides (MCTs) require protection from early gastric degradation. SINOFN utilizes cutting-edge liposomal and micro-encapsulation techniques that shield active molecules. This ensures targeted release in the intestinal tract, maximizing metabolic utility.
Leveraging specialized plant-extraction techniques, we harness natural cyclic AMP from jujube extracts to support cellular signaling and energy pathways in oncology-support foods. Our chemical-free extraction processes isolate bioactive structures without leaving trace solvents, meeting clean-label requirements for global medical institutions.
Whether formulating oral liquids, energy gels, or dry powders, managing viscosity and suspension stability is crucial for clinical liquid diets and tube feeding. Our formulation team designs systems that prevent sedimentation, keeping nutritional distribution uniform in every milliliter.
Combining automated engineering with comprehensive quality assurance to provide high-quality contract manufacturing.
10+ dedicated automated lines supporting softgels, clinical-grade gummies, dry powders, and tablets.
Equipped with HPLC/GC-MS for screening raw materials and validating dissolution and stability.
State-of-the-art facility for scaling formulations, optimizing bioavailability, and running pilot batches.
Monitored through smart systems, featuring batch tracking and BRCGS-certified storage.
SINOFN prioritizes intellectual property and strict manufacturing compliance, holding 36 patents (including 11 invention, 12 utility model, 11 software copyrights, and 2 designs) along with 71 multi-category trademarks. Our operations are fully certified under leading global frameworks.
Importing specialized medical foods into Canada requires navigate stringent local laws. Under Health Canada's Food and Drugs Act, particularly Division 24 (Foods for Special Dietary Use), products marketed as FSMP must meet exact formulation limits and labeling criteria.
SINOFN helps Calgary distributors and healthcare buyers clear these hurdles. Our team, led by formulation and regulatory experts, provides complete document transparency—including raw material origin assays, allergen screening, and microbial analysis. This speeds up compliance reviews and minimizes customs delays at the border.
Logistically, we utilize fast shipping networks routing through the Port of Vancouver directly to Calgary’s major distribution centers. Our specialized packaging safeguards active ingredients from temperature swings, ensuring they arrive at Alberta clinics in optimal condition.
Explore our targeted formulations, specialized dietary lines, and dosage systems developed for clients in Calgary.
Expert answers addressing the concerns of clinical buyers, brand owners, and logistics managers.
Contact our technical experts for custom formulations, pilot-run parameters, and compliance details.
Send Inquiry Now